Edmonds, WA, United States of America

Clay B Siegall




Average Co-Inventor Count = 2.6

ph-index = 12

Forward Citations = 421(Granted Patents)


Location History:

  • Seattle, WA (US) (1997 - 1998)
  • Edmonds, WA (US) (1996 - 2010)
  • Bothell, WA (US) (2010)

Company Filing History:


Years Active: 1996-2010

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Clay B. Siegall in Cancer Treatment

Introduction: Clay B. Siegall, an esteemed inventor based in Edmonds, WA, has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 15 patents to his name, Siegall's work primarily focuses on enhancing immune responses to combat cancer and related diseases.

Latest Patents: Among his most recent patents are methods for augmenting an immune response using anti-CD40 antibodies. This invention is pivotal as it relates to both the prevention and treatment of cancer, inflammatory diseases, and disorders of the immune system. Specifically, these methods involve the administration of a CD40 binding protein, which plays a crucial role by potentiating the binding of CD40 to its ligand. Another notable patent details methods for the treatment of cancer utilizing anti-CD40 antibodies, reinforcing his commitment to improving therapeutic strategies through innovative approaches.

Career Highlights: Siegall co-founded Seattle Genetics, Inc., where he served as the President and CEO, leading the company to significant breakthroughs in antibody-drug conjugates targeting cancer cells. He also held a position at Bristol-Myers Squibb Company, further solidifying his expertise and influence within the pharmaceutical and biotechnological industries.

Collaborations: Throughout his career, Siegall has collaborated with prominent professionals in his field, including notable coworkers such as Joseph A. Francisco and Alan F. Wahl. These partnerships have helped foster a collaborative environment for innovation and have contributed to the success of his projects.

Conclusion: With 15 patents reflecting his commitment to advancing treatment options for cancer and immune-related disorders, Clay B. Siegall stands out as a leading innovator in the biotechnology field. His work not only emphasizes the importance of research-based solutions but also showcases the potential of innovative methods in the fight against complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…